Can Novo Nordisk get its comeback going in 2026? Let's discuss two things that could materialize for the company next year ...
Health and Me on MSN
Ozempic launches in India at Rs 2,200 for starter dose: All you need to know
Novo Nordisk has launched its popular diabetes drug Ozempic in India, with the weekly 0.25 mg starter dose priced at ₹2,200.
Novo Nordisk has officially launched Ozempic for diabetes treatment in India. Let's learn more about how this injection works ...
Investor's Business Daily on MSN
Eli Lilly Rises, Again, After EMA Groups Recommends Mounjaro For Children As Young As 10
On Friday, an EMA committee recommended extending the use of Eli Lilly's type 2 diabetes drug, Mounjaro, to children as young ...
Media reports say that the U.S. Food and Drug Administration (FDA) is being pushed internally to fast-track approval of Eli ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...
Novo Nordisk A/S said its high-dose version of blockbuster Wegovy has been cleared by the European Union’s drug advisory board, opening the way for use of a shot that delivers more weight loss than ...
Dec 12 (Reuters) - The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's ...
Novo Nordisk launched Ozempic in India on Friday—and the weight-loss drug will sell at a massive discount there, compared ...
The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's blockbuster drug Mounjaro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback